SpectraCure AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was SEK 0.698 million compared to SEK 0.665 million a year ago. Net loss was SEK 5.98 million compared to SEK 7.02 million a year ago. Basic loss per share from continuing operations was SEK 0.06 compared to SEK 0.07 a year ago.
For the six months, revenue was SEK 1.57 million compared to SEK 1.57 million a year ago. Net loss was SEK 11.34 million compared to SEK 13.3 million a year ago. Basic loss per share from continuing operations was SEK 0.12 compared to SEK 0.14 a year ago.